abstract |
Flavin Adenine Dinucleotide (FAD) the present use relates to its use for the prevention and/or treatment of cancer. Advantageously, the FAD is at least partially encapsulated in the particle with a carrier to improve its absorption and distribution while limiting its destruction, in particular by blood hydrolytic enzymes. The present invention is in the field of medicine, more specifically oncology or cancerology. |